Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia.
Philippot Q, Fekkar A, Gervais A, Le Voyer T, Boers LS, Conil C, Bizien L, de Brabander J, Duitman JW, Romano A, Rosain J, Blaize M, Migaud M, Jeljeli M, Hammadi B, Desmons A, Marchal A; ArtDECO consortium; COVID HGE consortium; Mayaux J, Zhang Q, Jouanguy E, Borie R, Crestani B, Luyt CE, Adle-Biassette H, Sene D, Megarbane B, Cobat A, Bastard P, Bos LDJ, Casanova JL, Puel A. Philippot Q, et al. Among authors: fekkar a. J Clin Immunol. 2023 Aug;43(6):1093-1103. doi: 10.1007/s10875-023-01512-9. Epub 2023 May 20. J Clin Immunol. 2023. PMID: 37209324 Free PMC article.
Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.
Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S; EVAMICA study team. Cambau E, et al. Intensive Care Med. 2017 Nov;43(11):1613-1625. doi: 10.1007/s00134-017-4766-4. Epub 2017 Apr 3. Intensive Care Med. 2017. PMID: 28374097 Free PMC article. Clinical Trial.
Breakthrough invasive mould infections in patients treated with caspofungin.
Pang KA, Godet C, Fekkar A, Scholler J, Nivoix Y, Letscher-Bru V, Massias L, Kauffmann-Lacroix C, Elsendoorn A, Uzunov M, Datry A, Herbrecht R. Pang KA, et al. Among authors: fekkar a. J Infect. 2012 Apr;64(4):424-9. doi: 10.1016/j.jinf.2011.12.015. Epub 2011 Dec 29. J Infect. 2012. PMID: 22227384
Performance of Repeated Measures of (1-3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial.
Dupuis C, Le Bihan C, Maubon D, Calvet L, Ruckly S, Schwebel C, Bouadma L, Azoulay E, Cornet M, Timsit JF; Empiricus Study Group. Dupuis C, et al. Open Forum Infect Dis. 2021 Mar 2;8(3):ofab080. doi: 10.1093/ofid/ofab080. eCollection 2021 Mar. Open Forum Infect Dis. 2021. PMID: 33816643 Free PMC article.
Invasive Infections with Nannizziopsis obscura Species Complex in 9 Patients from West Africa, France, 2004-20201.
Garcia-Hermoso D, Hamane S, Fekkar A, Jabet A, Denis B, Siguier M, Galeazzi G, Haddad E, Brun S, Vidal V, Nevez G, Le Berre R, Gits-Muselli M, Lanternier F, Bretagne S. Garcia-Hermoso D, et al. Among authors: fekkar a. Emerg Infect Dis. 2020 Sep;26(9):2022-30. doi: 10.3201/eid2609.200276. Emerg Infect Dis. 2020. PMID: 32819454 Free PMC article.
Population Structure of Candida parapsilosis: No Genetic Difference Between French and Uruguayan Isolates Using Microsatellite Length Polymorphism.
Desnos-Ollivier M, Bórmida V, Poirier P, Nourrisson C, Pan D, Bretagne S, Puime A, Dromer F; French Mycoses Study Group; Uruguayan Invasive Fungal Infection Network. Desnos-Ollivier M, et al. Mycopathologia. 2018 Apr;183(2):381-390. doi: 10.1007/s11046-017-0224-7. Epub 2017 Nov 16. Mycopathologia. 2018. PMID: 29147867
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation.
Jullien V, Azoulay E, Schwebel C, Le Saux T, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Cour M, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Wolff M, Timsit JF; EMPIRICUS Trial Study Group. Jullien V, et al. J Antimicrob Chemother. 2017 Jan;72(1):181-189. doi: 10.1093/jac/dkw352. Epub 2016 Sep 8. J Antimicrob Chemother. 2017. PMID: 27609051 Free article. Clinical Trial.
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent Candida spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability.
Espinel-Ingroff A, Sasso M, Turnidge J, Arendrup M, Botterel F, Bourgeois N, Bouteille B, Canton E, Cassaing S, Dannaoui E, Dehais M, Delhaes L, Dupont D, Fekkar A, Fuller J, Garcia-Effron G, Garcia J, Gonzalez GM, Govender NP, Guegan H, Guinea J, Houzé S, Lass-Flörl C, Pelaez T, Forastiero A, Lackner M, Magobo R. Espinel-Ingroff A, et al. Among authors: fekkar a. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0109321. doi: 10.1128/AAC.01093-21. Epub 2021 Aug 9. Antimicrob Agents Chemother. 2021. PMID: 34370582 Free PMC article.
99 results